Clinical Trial Update: Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This clinical-trial update describes a Phase 1 study evaluating a combination of sorafenib, cetuximab, and irinotecan in patients with advanced or metastatic co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• ERBITUX (cetuximab)
• Nexavar (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Status: COMPLETED